Skip to content

Exelixis EXEL Inventories

Inventories at other companies

Eli Lilly logo
Eli LillyLLY
$14.49B+56.1%
Pfizer logo
PfizerPFE
$2.46B-11.9%
Incyte logo
IncyteINCY
$331.42M-9.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$5.56M-51.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$32.98M+734%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:InventoryGross.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's inventories?
Exelixis (EXEL) reported inventories of $63.91M in Q1 2026.
How has Exelixis's inventories changed year-over-year?
Exelixis's inventories decreased by 11.2% year-over-year, from $71.99M to $63.91M.
What is the long-term trend for Exelixis's inventories?
Over 5 years (2020 to 2025), Exelixis's inventories has grown at a 11.1% compound annual growth rate (CAGR), from $35.67M to $60.37M.
What does inventories mean?
The total value of all raw materials and finished products the company has in stock.
How do you interpret inventories?
An increase may signal anticipated demand growth or potential supply chain bottlenecks, whereas a decrease could indicate strong sales or inventory management efficiency.
How does inventories compare across companies?
Standard for manufacturing-based firms; biotech peers with commercial products maintain inventory levels aligned with market demand forecasts.